Vistagen Announces Phase 3 Program For Social Anxiety Disorder With Fasedienol; First Enrollment In U.S. Study For Efficacy, Safety, Tolerability During Public Speaking Challenge

BenzingaJan 10 08:37 ET

GH Research Said It Met Primary Endpoint In Phase 2a Proof-Of-Concept Trial In Postpartum Depression And Phase 2a Proof-Of-Concept Trial In Bipolar II Disorder With Current Major Depressive Episode

BenzingaJan 10 07:10 ET

NRx Stock Rallies 35% on Equity Purchases, Clinic Acquisition

Seeking AlphaJan 6 15:26 ET

HOPE Therapeutics And NRx Pharmaceuticals Announce Signing Of Binding Term Sheet For $27M In Funding For HOPE Clinic Acquisitions And Pharmaceutical Operations

BenzingaJan 6 10:17 ET

NRx Pharmaceuticals Subsidiary, HOPE Therapeutics, To Host Investor Workshop For Qualified Institutional Investors At Mar-A-Lago Club During the Week of January 6, 2025

BenzingaJan 3 08:10 ET

What's Going On With NRX Pharmaceuticals Stock Thursday?

BenzingaJan 2 13:14 ET